. | Unit . | Reference range . | . |
---|---|---|---|
| Tsd/µL | 4.3–10 | 10.02 (+) |
| Mio/µL | 4.50–5.90 | 5.26 |
| g/dL | 14.0–17.5 | 16.4 |
| % | 40–52 | 47 |
| fl | 82–101 | 90 |
| pg | 27–34 | 31 |
| g/dL | 31.5–36.0 | 35 |
| Tsd/µL | 140–440 | 134 (−) |
| s | 128–173 | 178.9 |
| Normal | Heteroz. | |
| Normal | Normal | |
| Normal | Normal | |
| ng/mL | <0.5 | 0.44 |
| µmol/L | 4.9–15.0 | 23.00 (+) |
| 1.0 | ||
| % | >70 | 92 |
| mg/L | <0.5 | 2.73 (+) |
| s | 25.1–37.7 | 44 (+) |
| mmol/L | 136–145 | 142 |
| mmol/L | 3.5–4.5 | 4.4 |
| mmol/L | 0.74–0.99 | 0.68 |
| U/L | <35 | 39 (+) |
| U/L | <50 | 61 |
| U/L | <55 | 40 |
| mg/dL | 0.70–1.30 | 1.33 |
| mL/min | >90 | 65 |
| mg/dL | <0.3 | 1.1 |
| % | 56–162 | 158.9 |
| % | 50–187 | 168 |
| Ratio | 1.06 (N) | |
| sec | 30.4–45.3 | 54.2 (+) |
| sec | 27.7–33.5 | 37.7 (+) |
| Ratio | < 1.2 | 1.44 (+) |
| sec | 30.4–45.3 | 44.4 |
| % | 60–168 | 145.7 |
| % | 70–120 | 111 |
| % | 70–140 | 74 |
| % | 70–120 | 135.5 (+) |
| % | 70–150 | 82 |
| % | 70–140 | >150 (+) |
| % | 64.7–115.3 | 118.5 (+) |
| s | 68–91 | 69.7 |
| Ratio | 0.86–1.10 | 0.90 |
| sec | 25–31 | 32.0 (+) |
| sec | 25–31 | 28.0 |
| Thrombocyte anisocytosis (N) | ||
| mg/dL | 180–350 | 363 (+) |
| pg/mL | 2.3–4.2 | 3.91 |
| ng/dL | 0.89–1.76 | 1.25 |
| µIE/mL | 0.55–4.78 | 3.04 |
| g/L | <0.3 | <0.10 |
| GPL-U/mL | <10 | 1.2 |
. | Unit . | Reference range . | . |
---|---|---|---|
| Tsd/µL | 4.3–10 | 10.02 (+) |
| Mio/µL | 4.50–5.90 | 5.26 |
| g/dL | 14.0–17.5 | 16.4 |
| % | 40–52 | 47 |
| fl | 82–101 | 90 |
| pg | 27–34 | 31 |
| g/dL | 31.5–36.0 | 35 |
| Tsd/µL | 140–440 | 134 (−) |
| s | 128–173 | 178.9 |
| Normal | Heteroz. | |
| Normal | Normal | |
| Normal | Normal | |
| ng/mL | <0.5 | 0.44 |
| µmol/L | 4.9–15.0 | 23.00 (+) |
| 1.0 | ||
| % | >70 | 92 |
| mg/L | <0.5 | 2.73 (+) |
| s | 25.1–37.7 | 44 (+) |
| mmol/L | 136–145 | 142 |
| mmol/L | 3.5–4.5 | 4.4 |
| mmol/L | 0.74–0.99 | 0.68 |
| U/L | <35 | 39 (+) |
| U/L | <50 | 61 |
| U/L | <55 | 40 |
| mg/dL | 0.70–1.30 | 1.33 |
| mL/min | >90 | 65 |
| mg/dL | <0.3 | 1.1 |
| % | 56–162 | 158.9 |
| % | 50–187 | 168 |
| Ratio | 1.06 (N) | |
| sec | 30.4–45.3 | 54.2 (+) |
| sec | 27.7–33.5 | 37.7 (+) |
| Ratio | < 1.2 | 1.44 (+) |
| sec | 30.4–45.3 | 44.4 |
| % | 60–168 | 145.7 |
| % | 70–120 | 111 |
| % | 70–140 | 74 |
| % | 70–120 | 135.5 (+) |
| % | 70–150 | 82 |
| % | 70–140 | >150 (+) |
| % | 64.7–115.3 | 118.5 (+) |
| s | 68–91 | 69.7 |
| Ratio | 0.86–1.10 | 0.90 |
| sec | 25–31 | 32.0 (+) |
| sec | 25–31 | 28.0 |
| Thrombocyte anisocytosis (N) | ||
| mg/dL | 180–350 | 363 (+) |
| pg/mL | 2.3–4.2 | 3.91 |
| ng/dL | 0.89–1.76 | 1.25 |
| µIE/mL | 0.55–4.78 | 3.04 |
| g/L | <0.3 | <0.10 |
| GPL-U/mL | <10 | 1.2 |
ALT, alanine transaminase; APC-FV, activated protein C resistance - Factor V; AST, aspartate transaminase; GFR, glomerular filtration rate; GGT, gamma-glutamyl transferase; INR, international normalized ratio; MCH, mean corpuscular haemoglobin content; MCHC,mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; NT-proBNP: N-terminal Prohormone of Brain Natriuretic Peptide; PTT, partial thromboplastin time; RBC, red blood cell; TSH, thyroid-stimulating hormone; WBC, white blood cell.
. | Unit . | Reference range . | . |
---|---|---|---|
| Tsd/µL | 4.3–10 | 10.02 (+) |
| Mio/µL | 4.50–5.90 | 5.26 |
| g/dL | 14.0–17.5 | 16.4 |
| % | 40–52 | 47 |
| fl | 82–101 | 90 |
| pg | 27–34 | 31 |
| g/dL | 31.5–36.0 | 35 |
| Tsd/µL | 140–440 | 134 (−) |
| s | 128–173 | 178.9 |
| Normal | Heteroz. | |
| Normal | Normal | |
| Normal | Normal | |
| ng/mL | <0.5 | 0.44 |
| µmol/L | 4.9–15.0 | 23.00 (+) |
| 1.0 | ||
| % | >70 | 92 |
| mg/L | <0.5 | 2.73 (+) |
| s | 25.1–37.7 | 44 (+) |
| mmol/L | 136–145 | 142 |
| mmol/L | 3.5–4.5 | 4.4 |
| mmol/L | 0.74–0.99 | 0.68 |
| U/L | <35 | 39 (+) |
| U/L | <50 | 61 |
| U/L | <55 | 40 |
| mg/dL | 0.70–1.30 | 1.33 |
| mL/min | >90 | 65 |
| mg/dL | <0.3 | 1.1 |
| % | 56–162 | 158.9 |
| % | 50–187 | 168 |
| Ratio | 1.06 (N) | |
| sec | 30.4–45.3 | 54.2 (+) |
| sec | 27.7–33.5 | 37.7 (+) |
| Ratio | < 1.2 | 1.44 (+) |
| sec | 30.4–45.3 | 44.4 |
| % | 60–168 | 145.7 |
| % | 70–120 | 111 |
| % | 70–140 | 74 |
| % | 70–120 | 135.5 (+) |
| % | 70–150 | 82 |
| % | 70–140 | >150 (+) |
| % | 64.7–115.3 | 118.5 (+) |
| s | 68–91 | 69.7 |
| Ratio | 0.86–1.10 | 0.90 |
| sec | 25–31 | 32.0 (+) |
| sec | 25–31 | 28.0 |
| Thrombocyte anisocytosis (N) | ||
| mg/dL | 180–350 | 363 (+) |
| pg/mL | 2.3–4.2 | 3.91 |
| ng/dL | 0.89–1.76 | 1.25 |
| µIE/mL | 0.55–4.78 | 3.04 |
| g/L | <0.3 | <0.10 |
| GPL-U/mL | <10 | 1.2 |
. | Unit . | Reference range . | . |
---|---|---|---|
| Tsd/µL | 4.3–10 | 10.02 (+) |
| Mio/µL | 4.50–5.90 | 5.26 |
| g/dL | 14.0–17.5 | 16.4 |
| % | 40–52 | 47 |
| fl | 82–101 | 90 |
| pg | 27–34 | 31 |
| g/dL | 31.5–36.0 | 35 |
| Tsd/µL | 140–440 | 134 (−) |
| s | 128–173 | 178.9 |
| Normal | Heteroz. | |
| Normal | Normal | |
| Normal | Normal | |
| ng/mL | <0.5 | 0.44 |
| µmol/L | 4.9–15.0 | 23.00 (+) |
| 1.0 | ||
| % | >70 | 92 |
| mg/L | <0.5 | 2.73 (+) |
| s | 25.1–37.7 | 44 (+) |
| mmol/L | 136–145 | 142 |
| mmol/L | 3.5–4.5 | 4.4 |
| mmol/L | 0.74–0.99 | 0.68 |
| U/L | <35 | 39 (+) |
| U/L | <50 | 61 |
| U/L | <55 | 40 |
| mg/dL | 0.70–1.30 | 1.33 |
| mL/min | >90 | 65 |
| mg/dL | <0.3 | 1.1 |
| % | 56–162 | 158.9 |
| % | 50–187 | 168 |
| Ratio | 1.06 (N) | |
| sec | 30.4–45.3 | 54.2 (+) |
| sec | 27.7–33.5 | 37.7 (+) |
| Ratio | < 1.2 | 1.44 (+) |
| sec | 30.4–45.3 | 44.4 |
| % | 60–168 | 145.7 |
| % | 70–120 | 111 |
| % | 70–140 | 74 |
| % | 70–120 | 135.5 (+) |
| % | 70–150 | 82 |
| % | 70–140 | >150 (+) |
| % | 64.7–115.3 | 118.5 (+) |
| s | 68–91 | 69.7 |
| Ratio | 0.86–1.10 | 0.90 |
| sec | 25–31 | 32.0 (+) |
| sec | 25–31 | 28.0 |
| Thrombocyte anisocytosis (N) | ||
| mg/dL | 180–350 | 363 (+) |
| pg/mL | 2.3–4.2 | 3.91 |
| ng/dL | 0.89–1.76 | 1.25 |
| µIE/mL | 0.55–4.78 | 3.04 |
| g/L | <0.3 | <0.10 |
| GPL-U/mL | <10 | 1.2 |
ALT, alanine transaminase; APC-FV, activated protein C resistance - Factor V; AST, aspartate transaminase; GFR, glomerular filtration rate; GGT, gamma-glutamyl transferase; INR, international normalized ratio; MCH, mean corpuscular haemoglobin content; MCHC,mean corpuscular haemoglobin concentration; MCV, mean corpuscular volume; NT-proBNP: N-terminal Prohormone of Brain Natriuretic Peptide; PTT, partial thromboplastin time; RBC, red blood cell; TSH, thyroid-stimulating hormone; WBC, white blood cell.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.